NCOA7 anticorps (N-Term)
Aperçu rapide pour NCOA7 anticorps (N-Term) (ABIN953618)
Antigène
Voir toutes NCOA7 AnticorpsReactivité
Hôte
Clonalité
Conjugué
Application
-
-
Épitope
- AA 82-112, N-Term
-
Specificité
- This antibody recognizes Human NCOA7 (N-term).
-
Purification
- Protein A column, followed by peptide affinity purification
-
Immunogène
- KLH conjugated synthetic peptide between 82~112 amino acids from the N-terminal region of human NCOA7
-
Isotype
- Ig Fraction
-
-
-
-
Indications d'application
- Optimal working dilution should be determined by the investigator.
-
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Concentration
- 0.25 mg/mL
-
Buffer
- PBS containing 0.09 % (W/V) Sodium Azide as preservative
-
Agent conservateur
- Sodium azide
-
Précaution d'utilisation
- This product contains sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Conseil sur la manipulation
- Avoid repeated freezing and thawing.
-
Stock
- 4 °C/-20 °C
-
Stockage commentaire
- Store undiluted at 2-8 °C for one month or (in aliquots) at -20 °C for longer.
-
-
- NCOA7 (Nuclear Receptor Coactivator 7 (NCOA7))
-
Autre désignation
- NCOA7
-
Sujet
- NCOA7 enhances the transcriptional activities of several nuclear receptors. It is involved in the coactivation of different nuclear receptors, such as ESR1, THRB, PPARG and RARA.Synonyms: 140 kDa estrogen receptor-associated protein, ERAP140, ESNA1, Estrogen nuclear receptor coactivator 1, Nuclear receptor coactivator 7
-
Poids moléculaire
- 106162 Da
-
ID gène
- 135112
-
NCBI Accession
- NP_001116314
-
Pathways
- Nuclear Hormone Receptor Binding
Antigène
-